Barbara Huisamen Selected Research

Barbara Huisamen Research Topics

Disease

9	Insulin Resistance 01/2022 - 07/2003
8	Infarction (Infarctions) 12/2020 - 12/2005
7	Reperfusion Injury 01/2022 - 11/2008
6	Obesity 03/2021 - 09/2012
5	Cardiotoxicity 10/2023 - 01/2019
5	Body Weight (Weight, Body) 01/2022 - 02/2011
4	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 02/2015
4	Hyperglycemia 04/2020 - 11/2016
2	Neoplasms (Cancer) 01/2022 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 02/2015 - 07/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2015 - 09/2012
1	Necrosis 10/2023
1	Cardiomyopathies (Cardiomyopathy) 10/2023
1	Prediabetic State (Prediabetes) 01/2022
1	Ischemia 01/2022
1	Breast Neoplasms (Breast Cancer) 03/2018
1	Starvation 03/2018
1	cyclopia sequence 01/2018
1	Contusions 01/2015
1	Weight Gain 10/2014
1	Cardiomegaly (Heart Hypertrophy) 10/2014
1	Body Weight Changes 10/2014
1	Diabetes Mellitus 12/2012
1	Hyperphagia (Overeating) 09/2012
1	Hypoxia (Hypoxemia) 01/2002

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 04/2020 - 07/2003
6	Insulin (Novolin)FDA Link 01/2022 - 02/2011
6	aspalathinIBA 01/2022 - 01/2017
6	Phosphotransferases (Kinase)IBA 01/2022 - 12/2005
6	MelatoninIBA 12/2020 - 11/2008
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 01/2020
3	FlavonoidsIBA 10/2023 - 01/2020
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 09/2012
2	Dacarbazine (DIC)FDA LinkGeneric 10/2023 - 01/2022
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022 - 01/2013
2	Glycogen Synthase Kinase 3IBA 01/2022 - 10/2013
2	PolyphenolsIBA 03/2021 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 04/2020 - 11/2016
2	Melatonin Receptors (Melatonin Receptor)IBA 08/2018 - 11/2008
2	dihydrochalconeIBA 01/2018 - 01/2017
2	Blood Glucose (Blood Sugar)IBA 01/2018 - 10/2014
2	Adrenergic Agents (Adrenergic Drugs)IBA 07/2014 - 11/2008
2	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2012 - 02/2011
1	Caspase 3 (Caspase-3)IBA 10/2023
1	7-hydroxyflavanoneIBA 10/2023
1	Protein Isoforms (Isoforms)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Mitogen-Activated Protein Kinase 3IBA 01/2022
1	AnthracyclinesIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2020
1	pinocembrinIBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2019
1	NF-E2-Related Factor 2IBA 08/2018
1	SirtuinsIBA 08/2018
1	Amino Acids FDA Link 03/2018
1	Nonesterified Fatty Acids (NEFA)IBA 03/2018
1	Adenosine Triphosphate (ATP)IBA 03/2018
1	LipidsIBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	sanguinarineIBA 06/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Apolipoproteins B (ApoB)IBA 01/2017
1	Ataxia Telangiectasia Mutated ProteinsIBA 02/2015
1	Diclofenac (SR 38)FDA LinkGeneric 01/2015
1	Formoterol Fumarate (Oxis)FDA Link 07/2014
1	CarbohydratesIBA 07/2014
1	phospholambanIBA 10/2013
1	Mitochondrial Permeability Transition PoreIBA 01/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2013
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 12/2012
1	Sucrose (Saccharose)IBA 09/2012
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2005
1	WortmanninIBA 12/2005
1	Mitogen-Activated Protein KinasesIBA 12/2005
1	Streptozocin (Streptozotocin)FDA Link 07/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2002
1	Cyclic NucleotidesIBA 01/2002

Therapy/Procedure

1	Complementary Therapies (Alternative Medicine) 01/2022